SharpeIQ Research
Earnings reactions
One note per company per quarter, from the issuer’s own earnings release. The move is the stock’s reaction. The 30-day ATM column is context, not the event premium. 1,721 notes.
| Company | Period | Move | 30d ATM | Filed |
|---|---|---|---|---|
| SPRUSpruce Power Holding Corporation | Q3 FY2026 | pending | — | Nov 13, 2026 |
| NSPRInspireMD, Inc. | FY2026 | pending | — | Nov 13, 2026 |
| STROSutro Biopharma, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SPROSpero Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| LSFLaird Superfood, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| DMACDiaMedica Therapeutics Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SPCEVirgin Galactic Holdings, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| PROPPrairie Operating Co. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| VRCAVerrica Pharmaceuticals Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| NKTRNektar Therapeutics | Q3 FY2026 | +0.1% | — | Nov 13, 2026 |
| FGIFGI Industries Ltd. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| ENSCEnsysce Biosciences, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| CRDFCardiff Oncology, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| VATEINNOVATE Corp. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| CTSOCytoSorbents Corporation | Q3 FY2026 | pending | — | Nov 13, 2026 |
| ANABAnaptysBio, Inc. | Q1 FY2026 | -3.2% | — | Nov 13, 2026 |
| RCKTRocket Pharmaceuticals, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| GCTSGCT Semiconductor Holding, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| CBIOCrescent Biopharma, Inc. | FY2026 | -1.5% | — | Nov 13, 2026 |
| IMMXImmix Biopharma, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| KLCKinderCare Learning Companies, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| TACTTransAct Technologies Incorporated | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SERSerina Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| OFRMOnce Upon a Farm, PBC | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SRTSSensus Healthcare, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| BCDABioCardia, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| PLRXPliant Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| INVEINVE Technologies, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| LFMDLifeMD, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| OPHCOptimumBank Holdings, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| RLMDRelmada Therapeutics, Inc. | Q3 FY2026 | +1.2% | — | Nov 13, 2026 |
| UAMYUnited States Antimony Corporation | Q3 FY2026 | +6.2% | — | Nov 13, 2026 |
| LCTXLineage Cell Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| ELDNEledon Pharmaceuticals, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| RKDAArcadia Biosciences, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| REKRRekor Systems, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| IDNIntellicheck, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| NPCENeuroPace, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| HQIHireQuest | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SLSNSolésence, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| DERMJourney Medical Corporation | Q3 FY2026 | pending | — | Nov 13, 2026 |
| PRMEPrime Medicine, Inc. | FY2026 | +9.8% | — | Nov 13, 2026 |
| GUTSFractyl Health, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| IZEAIZEA Worldwide, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| LWAYLifeway Foods, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| AMATApplied Materials, Inc. | Q4 FY2026 | -2.7% | — | Nov 13, 2026 |
| VTSIVirTra, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| ANDGAndersen Group Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| SMSISmith Micro Software, Inc. | Q3 FY2026 | pending | — | Nov 13, 2026 |
| ARWRArrowhead Pharmaceuticals, Inc. | FY2026 | +1.3% | — | Nov 13, 2026 |
| ARTNAArtesian Resources Corporation | Q3 FY2026 | pending | — | Nov 13, 2026 |
| TCITranscontinental Realty Investors, Inc. | FY2026 | pending | — | Nov 13, 2026 |
| ARLAmerican Realty Investors, Inc. | FY2026 | pending | — | Nov 13, 2026 |
| IORIncome Opportunity Realty Investors, Inc. | FY2026 | pending | — | Nov 13, 2026 |
| TRTTrio-Tech International | Q1 FY2027 | pending | — | Nov 13, 2026 |
| SGASaga Communications, Inc. | FY2026 | pending | — | Nov 12, 2026 |
| MPTIM-tron Industries, Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| NSYSNortech Systems Incorporated | Q3 FY2026 | pending | — | Nov 12, 2026 |
| ONDSOndas Inc. | Q3 FY2026 | -7.2% | — | Nov 12, 2026 |
| SESSES AI | Q3 FY2026 | pending | — | Nov 12, 2026 |
| SPHSuburban Propane Partners, L.P. | Q4 FY2026 | -1.9% | — | Nov 12, 2026 |
| FRMMForum Markets, Incorporated | Q3 FY2026 | pending | — | Nov 12, 2026 |
| SLNSilence Therapeutics plc | Q3 FY2026 | pending | — | Nov 12, 2026 |
| AKTSAktis Oncology, Inc. | Q3 FY2026 | -4.5% | — | Nov 12, 2026 |
| COHNCohen & Company Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| MNPRMonopar Therapeutics Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| IMNNIMUNON, Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| CRMDCorMedix Therapeutics | Q3 FY2026 | pending | — | Nov 12, 2026 |
| ENVXEnovix Corporation | Q3 FY2026 | -28.7% | — | Nov 12, 2026 |
| TSHATaysha Gene Therapies, Inc. | Q3 FY2026 | -1.6% | — | Nov 12, 2026 |
| FBYDFalcon’s Beyond Global, Inc. | Q3 FY2026 | -11.7% | — | Nov 12, 2026 |
| CAPSCapstone Holding Corp. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| ALTAltimmune, Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| LUNRIntuitive Machines, Inc. | Q3 FY2026 | +7.0% | — | Nov 12, 2026 |
| TWSTTwist Bioscience Corporation | Q4 FY2026 | -6.8% | — | Nov 12, 2026 |
| GENBGenerate Biomedicines, Inc. | Q3 FY2026 | -6.8% | — | Nov 12, 2026 |
| ABSIAbsci Corporation | Q3 FY2026 | pending | — | Nov 12, 2026 |
| DAIOData I/O Corporation | Q3 FY2026 | pending | — | Nov 12, 2026 |
| EYPTEyePoint, Inc. | Q3 FY2026 | -11.1% | — | Nov 12, 2026 |
| CYNCyngn | Q3 FY2026 | pending | — | Nov 12, 2026 |
| KPRXKiora Pharmaceuticals, Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| BWENBroadwind | Q3 FY2026 | pending | — | Nov 12, 2026 |
| AVAHAveanna Healthcare Holdings Inc. | FY2026 | -6.5% | -28.3pt | Nov 12, 2026 |
| FIGRFigure Technology Solutions | FY2026 | +6.1% | — | Nov 12, 2026 |
| SPBSpectrum Brands Holdings, Inc. | Q4 FY2026 | +0.1% | — | Nov 12, 2026 |
| CDNLCardinal Infrastructure Group Inc. | Q3 FY2026 | -62.4% | — | Nov 12, 2026 |
| EIKNEikon Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 12, 2026 |
| WWWWolverine World Wide, Inc. | Q3 FY2026 | +4.3% | — | Nov 12, 2026 |
| YETIYETI Holdings, Inc. | Q3 FY2026 | -10.5% | — | Nov 12, 2026 |
| EPCEdgewell Personal Care Company | Q4 FY2026 | -1.4% | — | Nov 12, 2026 |
| EYENational Vision Holdings, Inc. | Q3 FY2026 | +2.6% | — | Nov 12, 2026 |
| AHTAshford Hospitality Trust, Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| DTCXDatacentrex, Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| MRDNMeridian Holdings Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| IKTInhibikase Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| GPROGoPro, Inc. | FY2026 | pending | — | Nov 11, 2026 |
| PRMEPrime Medicine, Inc. | Q2 FY2026 | +10.3% | — | Nov 11, 2026 |
| DRMADermata Therapeutics, Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| TELATELA Bio, Inc. | Q3 FY2026 | pending | — | Nov 11, 2026 |
| PWCMPowerCompute | FY2026 | pending | — | Nov 10, 2026 |